1h Free Analyst Time
The liposomal products market is forecast to grow by USD 3.99 billion during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the liposomal products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of fungal disorders, growing prevalence of cancer cases, and many side effects are associated with cancer treatment.
The liposomal products market is segmented as below:
By Application
- Cancer
- Fungal infections
- Pain management
- Viral vaccines
- Photodynamic therapy
By Type
- Branded
- Generic
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the liposomal products market covers the following areas:
- Liposomal products market sizing
- Liposomal products market forecast
- Liposomal products market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global liposomal products market: Acthera Therapeutics AG, Bausch Lomb Corp., Baxter International Inc., Galen Ltd., GENFIT SA, Gilead Sciences Inc., Innocan Pharma Corp. Ltd., Johnson and Johnson Services Inc., Leadiant Biosciences Inc., Lipella Pharmaceuticals Inc., Liposoma B.V., Merrimack Pharmaceuticals Inc., Nanovex Biotechnologies SL, Pacira BioSciences Inc., Spectrum Pharmaceuticals Inc., Taiwan Liposome Co. Ltd., Takeda Pharmaceutical Co. Ltd., The Lubrizol Corp., Vascular Biosciences, and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising adoption of quality by design (QBD) over traditional processes."
According to the report, one of the major drivers for this market is the rising incidence of fungal disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acthera Therapeutics AG
- Bausch Lomb Corp.
- Baxter International Inc.
- Galen Ltd.
- GENFIT SA
- Gilead Sciences Inc.
- Innocan Pharma Corp. Ltd.
- Johnson and Johnson Services Inc.
- Leadiant Biosciences Inc.
- Lipella Pharmaceuticals Inc.
- Liposoma B.V.
- Merrimack Pharmaceuticals Inc.
- Nanovex Biotechnologies SL
- Pacira BioSciences Inc.
- Spectrum Pharmaceuticals Inc.
- Taiwan Liposome Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- The Lubrizol Corp.
- Vascular Biosciences
- Viatris Inc.
